Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

2.

Mortality benefits of influenza vaccination in elderly people.

Thijs C, Beyer WE, Govaert PM, Sprenger MJ, Dinant GJ, Knottnerus A.

Lancet Infect Dis. 2008 Aug;8(8):460-1; author reply 463-5. doi: 10.1016/S1473-3099(08)70161-0. No abstract available.

PMID:
18652989
3.

European Antimicrobial Resistance Surveillance System (EARSS): objectives and organisation.

Bronzwaer SL, Goettsch W, Olsson-Liljequist B, Wale MC, Vatopoulos AC, Sprenger MJ.

Euro Surveill. 1999 Apr;4(4):41-44.

PMID:
12631906
4.

Surveillance of respiratory pathogens and influenza-like illnesses in general practices - The Netherlands, winter 1997-98.

Heijnen ML, Dorigo-Zetsma JW, Bartelds AI, Wilbrink B, Sprenger MJ.

Euro Surveill. 1999 Jul;4(7):81-84.

PMID:
12631895
5.

[Pharmaco-economic evaluations of new drugs: potential key to a more efficient allocation of the health care budget].

Delwel GO, Sprenger MJ.

Ned Tijdschr Geneeskd. 2002 Jun 8;146(23):1068-71. Dutch.

PMID:
12085554
6.

A European study on the relationship between antimicrobial use and antimicrobial resistance.

Bronzwaer SL, Cars O, Buchholz U, Mölstad S, Goettsch W, Veldhuijzen IK, Kool JL, Sprenger MJ, Degener JE; European Antimicrobial Resistance Surveillance System.

Emerg Infect Dis. 2002 Mar;8(3):278-82.

7.

Standardization and quality assurance for antimicrobial resistance surveillance of Streptococcus pneumoniae and Staphylococcus aureus within the European Antimicrobial Resistance Surveillance System (EARSS).

Goettsch W, Bronzwaer SL, de Neeling AJ, Wale MC, Aubry-Damon H, Olsson-Liljequist B, Sprenger MJ, Degener JE.

Clin Microbiol Infect. 2000 Feb;6(2):59-63. No abstract available.

8.
9.

An age-period-cohort analysis of 50,875 AIDS cases among injecting drug users in Europe.

Houweling H, Wiessing LG, Hamers FF, Termorshuizen F, Gill ON, Sprenger MJ.

Int J Epidemiol. 1999 Dec;28(6):1141-8.

PMID:
10661660
10.

Economic evaluation of influenza vaccination. Assessment for The Netherlands.

Postma MJ, Bos JM, van Gennep M, Jager JC, Baltussen R, Sprenger MJ.

Pharmacoeconomics. 1999;16 Suppl 1:33-40. Review.

PMID:
10623374
11.

Resistance in Campylobacter species: increased resistance to fluoroquinolones and seasonal variation.

Talsma E, Goettsch WG, Nieste HL, Schrijnemakers PM, Sprenger MJ.

Clin Infect Dis. 1999 Oct;29(4):845-8.

PMID:
10589901
12.

[European strategy for control of resistance to antibiotics].

Sprenger MJ, Degener JE, Kullberg BJ, van der Meer JW, Mevius DJ, Stobberingh EE.

Ned Tijdschr Geneeskd. 1999 Jun 19;143(25):1322-5. Dutch.

PMID:
10416488
13.

[Infections and bacterial resistance in the community].

Goettsch WG, Goossens H, de Neeling AJ, Sprenger MJ.

Ned Tijdschr Geneeskd. 1999 Jun 19;143(25):1296-9. Review. Dutch.

PMID:
10416482
14.

EU conference 'The Microbial Threat'.

Mevius DJ, Sprenger MJ, Wegener HC.

Int J Antimicrob Agents. 1999 Feb;11(2):101-5.

PMID:
10221412
15.

[Surveillance of communicable diseases in the European Union].

Sprenger MJ, Bootsma PA, Reintjes R.

Ned Tijdschr Geneeskd. 1998 Oct 31;142(44):2418-23. Dutch.

PMID:
9864541
16.

[More information on infectious diseases provided by a national information system].

Sprenger MJ, Schrijnemakers PM.

Ned Tijdschr Geneeskd. 1998 Aug 22;142(34):1923-6. Dutch.

PMID:
9856180
17.

Estimating influenza-related hospitalization in The Netherlands.

Baltussen RM, Reinders A, Sprenger MJ, Postma MJ, Jager JC, Ament AJ, Leidl RM.

Epidemiol Infect. 1998 Aug;121(1):129-38.

18.

Community acquired infections and bacterial resistance.

Goossens H, Sprenger MJ.

BMJ. 1998 Sep 5;317(7159):654-7. Review. No abstract available.

19.

Risk of gastroenteritis among triathletes in relation to faecal pollution of fresh waters.

van Asperen IA, Medema G, Borgdorff MW, Sprenger MJ, Havelaar AH.

Int J Epidemiol. 1998 Apr;27(2):309-15.

PMID:
9602415
20.

[Influenza A(H5N1): current status].

Heijnen ML, Dorigo-Zetsma JW, de Jong JW, Sprenger MJ.

Tijdschr Diergeneeskd. 1998 Feb 1;123(3):86-7. Dutch. No abstract available.

PMID:
9599174
21.

Prevalence and risk factors for hepatitis B virus infections among visitors to an STD clinic.

van Duynhoven YT, van de Laar MJ, Schop WA, Rothbarth PH, van der Meijden WI, van Loon AM, Sprenger MJ.

Genitourin Med. 1997 Dec;73(6):488-92.

22.

[Indications for influenza vaccination in children with lung disorders. Dutch Association for Pediatric Medicine].

Neijens HJ, Rothbarth PH, Sprenger MJ.

Ned Tijdschr Geneeskd. 1997 Nov 15;141(46):2213-7. Review. Dutch.

PMID:
9550781
23.

Different demographic and sexual correlates for chlamydial infection and gonorrhoea in Rotterdam.

Van Duynhoven YT, van de Laar MJ, Schop WA, Mouton JW, van der Meijden WI, Sprenger MJ.

Int J Epidemiol. 1997 Dec;26(6):1373-85.

PMID:
9447420
24.

Influenza vaccination in 22 developed countries: an update to 1995.

Fedson DS, Hirota Y, Shin HK, Cambillard PE, Kiely J, Ambrosch F, Hannoun C, Leese J, Sprenger MJ, Hampson AW, Bro-Jørgensen K, Ahlbom AM, Nøkleby H, Valle M, Olafsson O, Salmerón F, Cloetta J, Rebelo de Andrade H, Snacken R, Donatelli I, Jennings LC, Strikas RA.

Vaccine. 1997 Oct;15(14):1506-11.

PMID:
9330460
25.

[Cost-effectiveness of influenza vaccination The Netherlands].

Reinders A, Postma MJ, Govaert TM, Sprenger MJ.

Ned Tijdschr Geneeskd. 1997 Jan 11;141(2):93-7. Dutch.

PMID:
9036354
26.

Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults.

Beyer WE, Palache AM, Sprenger MJ, Hendriksen E, Tukker JJ, Darioli R, van der Water GL, Masurel N, Osterhaus AD.

Vaccine. 1996 Oct;14(14):1331-9.

PMID:
9004442
27.

Antibody response to tetravalent influenza subunit vaccine in patients infected with human immunodeficiency virus type 1.

Schneider MM, Sprenger MJ, Hoepelman IM, van der Graaf Y, Borleffs JC.

Int J Antimicrob Agents. 1996 Apr;6(4):195-200.

PMID:
18611709
28.

Surveillance of gastroenteritis.

Borgdorff MW, Koopmans MP, Goosen ES, Sprenger MJ.

Lancet. 1995 Sep 23;346(8978):842-3. No abstract available.

PMID:
7674765
29.

[Prevalence of HIV infection among drug users in Zuid-Limburg].

Wiessing LG, Houweling H, Meulders WA, Cerdá E, Jansen M, Sprenger MJ.

Ned Tijdschr Geneeskd. 1995 Sep 23;139(38):1936-40. Dutch.

PMID:
7477534
30.

[Whooping cough in The Netherlands, 1989-1994].

de Melker HE, Conyn-van Spaendonck MA, Rümke HC, Sprenger MJ, Schellekens JF.

Ned Tijdschr Geneeskd. 1995 Jun 24;139(25):1280-6. Dutch.

PMID:
7609803
31.

Sense and nonsense of influenza vaccination in asthma and chronic obstructive pulmonary disease.

Rothbarth PH, Kempen BM, Sprenger MJ.

Am J Respir Crit Care Med. 1995 May;151(5):1682-5; discussion 1685-6.

PMID:
7735634
32.

Influenza vaccination in 18 developed countries, 1980-1992.

Fedson DS, Hannoun C, Leese J, Sprenger MJ, Hampson AW, Bro-Jørgensen K, Ahlbom AM, Nøkelby H, Valle M, Olafsson O, et al.

Vaccine. 1995 May;13(7):623-7.

PMID:
7668032
33.

The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial.

Govaert TM, Thijs CT, Masurel N, Sprenger MJ, Dinant GJ, Knottnerus JA.

JAMA. 1994 Dec 7;272(21):1661-5.

PMID:
7966893
34.

Immune response to influenza vaccination of elderly people. A randomized double-blind placebo-controlled trial.

Govaert TM, Sprenger MJ, Dinant GJ, Aretz K, Masurel N, Knottnerus JA.

Vaccine. 1994 Oct;12(13):1185-9.

PMID:
7839722
35.

Detection of respiratory syncytial virus by RNA-polymerase chain reaction and differentiation of subgroups with oligonucleotide probes.

van Milaan AJ, Sprenger MJ, Rothbarth PH, Brandenburg AH, Masurel N, Claas EC.

J Med Virol. 1994 Sep;44(1):80-7.

PMID:
7798890
36.

Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial.

Govaert TM, Dinant GJ, Aretz K, Masurel N, Sprenger MJ, Knottnerus JA.

BMJ. 1993 Oct 16;307(6910):988-90.

37.

Prospective application of reverse transcriptase polymerase chain reaction for diagnosing influenza infections in respiratory samples from a children's hospital.

Claas EC, van Milaan AJ, Sprenger MJ, Ruiten-Stuiver M, Arron GI, Rothbarth PH, Masurel N.

J Clin Microbiol. 1993 Aug;31(8):2218-21.

38.

Impact of influenza on mortality in relation to age and underlying disease, 1967-1989.

Sprenger MJ, Mulder PG, Beyer WE, Van Strik R, Masurel N.

Int J Epidemiol. 1993 Apr;22(2):334-40.

PMID:
8505193
39.

[Polymyalgia rheumatica and influenza vaccination].

Beijer WE, Sprenger MJ, Masurel N.

Dtsch Med Wochenschr. 1993 Feb 5;118(5):164-5. German. No abstract available.

PMID:
8432239
40.

Antibody response after influenza immunization with various vaccine doses: a double-blind, placebo-controlled, multi-centre, dose-response study in elderly nursing-home residents and young volunteers.

Palache AM, Beyer WE, Sprenger MJ, Masurel N, de Jonge S, Vardy A, Charpentier B, Noury J, van Beek WC, Borst RJ, et al.

Vaccine. 1993;11(1):3-9.

PMID:
8427034
41.

Improvement of the immunoglobulin subclass response to influenza vaccine in elderly nursing-home residents by the use of high-dose vaccines.

Remarque EJ, van Beek WC, Ligthart GJ, Borst RJ, Nagelkerken L, Palache AM, Sprenger MJ, Masurel N.

Vaccine. 1993;11(6):649-54.

PMID:
8322488
42.

Influenza vaccines: the effect of vaccine dose on antibody response in primed populations during the ongoing interpandemic period. A review of the literature.

Palache AM, Beyer WE, Lüchters G, Völker R, Sprenger MJ, Masurel N.

Vaccine. 1993;11(9):892-908. Review.

PMID:
8212834
43.

[Influenza vaccination and Postal Box 51-campaign].

Sprenger MJ, Masurel N.

Ned Tijdschr Geneeskd. 1992 Oct 3;136(40):1968-70. Dutch. No abstract available.

PMID:
1407180
44.

Type-specific identification of influenza viruses A, B and C by the polymerase chain reaction.

Claas EC, Sprenger MJ, Kleter GE, van Beek R, Quint WG, Masurel N.

J Virol Methods. 1992 Sep;39(1-2):1-13.

PMID:
1430057
45.

[Influenza vaccination; encourage or wait and see?].

Bouter KP, Diepersloot RJ, Masurel N, Sprenger MJ.

Ned Tijdschr Geneeskd. 1992 Jun 27;136(26):1271. Dutch. No abstract available.

PMID:
1620261
46.

Electronic influenza surveillance.

Sprenger MJ, Kempen BM, Hannoun C, Masurel N.

Lancet. 1992 Apr 4;339(8797):874. No abstract available.

PMID:
1347885
47.

Acute respiratory failure during pneumonia induced by Sendai virus.

van Daal GJ, Eijking EP, So KL, Fievez RB, Sprenger MJ, van Dam DW, Erdmann W, Lachmann B.

Adv Exp Med Biol. 1992;316:319-26.

PMID:
1337653
48.

Influenza: relation of mortality to morbidity parameters--Netherlands, 1970-1989.

Sprenger MJ, Mulder PG, Beyer WE, Masurel N.

Int J Epidemiol. 1991 Dec;20(4):1118-24.

PMID:
1800412
49.

[Minority viewpoint on influenza vaccination in the elderly].

Sprenger MJ, Desmyter J, Masurel N.

Ned Tijdschr Geneeskd. 1991 Nov 23;135(47):2208-10. Dutch. No abstract available.

PMID:
1956453
50.

[Influenza in the 1990/'91 season; composition of vaccine for the 1991/'92 season].

Sprenger MJ, Diepersloot RJ, Janssen J, Arron GI, Claas E, Masurel N.

Ned Tijdschr Geneeskd. 1991 Sep 21;135(38):1767-9. Dutch. No abstract available.

PMID:
1922538

Supplemental Content

Loading ...
Support Center